ProShares Ultra Health Care (RXL) 최신 뉴스, 시장 업데이트 및 심리 | Edgen
뒤로
집
주식
RXL
ProShares Ultra Health Care (RXL)
RXL 주가 차트
RXL
ProShares Ultra Health Care
$56.59
-1.27%
$-0.72
종가: Sep 10, 16:00:00 GMT-4
$56.59
0%
$0
애프터마켓: Sep 10, 20:00:00 GMT-4
개요
예보
보유고
뉴스
기사
주요 통계
이전 종가
$57.32
시가
$56.96
일일 범위
$56.55 - $57.47
52주 범위
$39.32 - $64.59
거래량
6.0K
평균 거래량
11.1K
배당수익률
1.55%
순자산
$0
NAV
--
비용 비율
--
발행 주식 수
1.5M
RXL란 무엇인가요?
RXL was created on 2007-01-30 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. RXL provides 2x leveraged exposure to a cap-weighted index of US health care companies.
기능
주식 및 암호화폐용 AI Copilot
가격 예측
후원 추적기
암호화폐 비교
메인 페이지
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
이용약관
개인정보 처리방침
사이트맵
© 2026 Edgen에서 제공
Merck lifts pipeline target to $70B as KEYTRUDA cliff nears
Sep 10 2026, 10:37
Amgen falls 10% as Novartis Lp(a) trial failure clouds drug class
Sep 08 2026, 17:27
Moderna-Merck vaccine clears Phase 3, stock jumps 177% on melanoma data
Sep 06 2026, 18:55
Viking Therapeutics trades below targets as VK2735 oral safety questioned
Sep 06 2026, 00:57
Gilead's third FDA approval in 4 months lifts turnaround case
Sep 05 2026, 16:28
AbbVie closes $10.9B Apogee deal to expand immunology pipeline
Sep 03 2026, 13:01
Ivonescimab beats Keytruda on survival in 4th phase 3 win
Sep 02 2026, 22:28
Moderna stock doubles in August after melanoma trial win with Merck
Sep 01 2026, 11:27
Lilly Taltz-Zepbound combo sustains 30.6% skin-clearance goal at 52 weeks
Aug 31 2026, 14:34
Eli Lilly to buy Merida Biosciences for up to $2.875 billion
Aug 31 2026, 14:14
Amgen's Repatha cuts death risk 20% in high-risk primary prevention trial
Aug 31 2026, 12:24
Moderna stock surges 127% as cancer vaccine reshapes biotech outlook
Aug 30 2026, 17:52
Eli Lilly GLP-1 sales surge 48% as employer coverage falls to 60%
Aug 28 2026, 20:22
FDA approves Lilly's Mounjaro to cut cardiovascular risk 8%
Aug 28 2026, 12:35
Gilead's Bixlenvo wins FDA approval as first single-tablet HIV option
Aug 27 2026, 22:26
Pfizer, BioNTech win FDA approval for XFG COVID vaccine, 5B doses
Aug 27 2026, 20:54
FDA clears Roche, Eli Lilly Alzheimer's blood test for 55-plus patients
Aug 27 2026, 15:55
Tezspire meets EoE trial goals, expanding to 470,000 US patient pool
Aug 27 2026, 10:27